Distinguished in Budd-Chiari Syndrome

Odile Goria

Rouen, FR 
Distinguished in Budd-Chiari Syndrome
Rouen, FR 
OverviewLocationsClinical Research

Overview

Odile Goria practices in Rouen, France. Ms. Goria is rated as a Distinguished expert by MediFind in the treatment of Budd-Chiari Syndrome. Her top areas of expertise are Budd-Chiari Syndrome, Mesenteric Venous Thrombosis, Autoimmune Hepatitis, Hepatitis, and Liver Transplant.

Her clinical research consists of co-authoring 40 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Budd-Chiari Syndrome.

Gender
Female

Locations

Rouen, France
Other Locations
Clichy-sous-bois, France
Lille, France
Paris, France
Hôpital St Joseph, Marseille, France
France
Bondy, France
Tours, France
Caen, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
Evaluation of the Efficacy of an Antibiotic Combined With Standard Treatment in Severe Alcoholic Hepatitis
Evaluation of the Efficacy of an Antibiotic Combined With Standard Treatment in Severe Alcoholic Hepatitis
Enrollment Status: Completed
Publish Date: March 25, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

40 Total Publications

Hepatopulmonary syndrome in patients with porto-sinusoidal vascular disorder: Characteristics and outcome.
Hepatopulmonary syndrome in patients with porto-sinusoidal vascular disorder: Characteristics and outcome.
Journal: JHEP reports : innovation in hepatology
Published: June 22, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Goria's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile